Skip to content

Application of ultrasound-guided thoracoabdominal nerve block combined with lateral oblique plane block in postoperative analgesia in patients undergoing nephrectomy

Application of ultrasound-guided thoracoabdominal nerve block combined with lateral oblique plane block in postoperative analgesia in patients undergoing nephrectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085105
Enrollment
Unknown
Registered
2024-05-31
Start date
2024-06-15
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney tumor

Interventions

Control group (Group A):The patient do not receive nerve block before surgery, and postoperative patient-controlled intravenous analgesia (PCIA) is used to control postoperative pain.
Simple thoracoabdominal nerve block group (Group B):After induction of general anesthesia, the patient underwent ultrasound-guided thoracoabdominal nerve block (M-TAPA) for postoperative analgesia, wi
Thoracic and abdominal nerve block combined with lateral oblique plane block group (Group C):After induction of general anesthesia, ultrasound-guided thoracoabdominal nerve combined with external obli

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Patients who plan to undergo laparoscopic simple (partial) nephrectomy; (2) ASA classification levels I-III; (3) Age: 18-85 years old; (4) Gender: male or female; (5) Fully informed and sign informed consent form.

Exclusion criteria

Exclusion criteria: (1) Concomitant severe liver and kidney dysfunction diseases; (2) Patients with allergies to local anesthetics, general anesthetics, and non steroidal antipyretic, analgesic, and anti-inflammatory drugs; (3) There are unstable cardiovascular disease conditions, such as heart failure, arrhythmia, and severe valve disease; (4) Coagulation dysfunction; (5) Other interference test results.

Design outcomes

Primary

MeasureTime frame
Numerical rating scale, NRS;

Secondary

MeasureTime frame
Opioid dosage;Stay time in recovery room ;Blood pressure;Heart rate;Surgical time;Blood creatinine;White blood cells;Time of getting out of bed afteroperation;Postoperative average length of hospital stay;Blood alanine transaminase;Blood aspartate aminotransferase;Blood Urea Nitrogen;Neutrophil percentage;

Countries

China

Contacts

Public ContactJun Dong

The First Affiliated Hospital of Chongqing Medical University

dongjun441@163.com+86 136 5838 9626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026